The current valuation score of Collplant Biotechnologies Ltd is 6.79, ranking 257 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.29, which is 0.00% below the recent high of -0.29 and -4527.33% above the recent low of -13.41.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.